|
Developed and refined over seven years, Hemodyne’s
remarkable Hemostasis Analysis System sets a new standard in platelet
and clotting assessment—an advanced level of diagnosis and control made
possible by the system’s unique ability to supply the “Whole Story.”
The Hemostasis Analysis System offers the most
comprehensive assessment of increased and decreased platelet activity,
as well as clot quality.
In minutes, physicians and researchers using the HAS
can assess bleeding risk, accurately dose and monitor a wide range of
cardiac and blood disorder drugs, assess cardiovascular risk, and gauge
platelet viability.
Please see additional information on the Hemostasis
Analysis System using the menu at left.
|
